In this episode of the DASON Digest, we discuss Chris Bland's study on IV push cefepime for Pseudomonas aeruginosa and the implications of these findings. The article can be found here: https://pubmed.ncbi.nlm.nih.gov/41166592/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Join ID Pharmacy Resident Paul Puccio as he speaks with Dr. Arielle Cohen, an ID Fellow at Duke University, is about the antimicrobial updates in the 2026 Surviving Sepsis Campaign guidelines. They focus on timing of antibiotic initiation, antimicrobial coverage, and rapid diagnostic tests and what this means for the treatment of sepsis and septic shock. The guidelines can be viewed here: https://pubmed.ncbi.nlm.nih.gov/41870560/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

In this episode of the DASON Digest, we discuss Dr. Amy Kang’s study on antimicrobial transition errors from hospitals to skilled nursing facilities, highlighting that nearly one-third of patients experience errors and why stewardship efforts must extend beyond hospital discharge to improve continuity, safety, and infection outcomes. The article from the episode can be viewed here: https://pubmed.ncbi.nlm.nih.gov/41852555/

For more information about DASON, please visit: https://dason.medicine.duke.edu/